The colocalization of XPO1 and NUP214 could be inhibited by the XPO1 inhibitor Selinexor/KPT-330, but the sensitivity of HOX gene expression to this XPO1 inhibitor seems to differ between AML cell lines. The gene discussed is NUP214; the disease is acute myeloid leukemia.